METHOD OF USING A CYCLOOXYGENASE-2 INHIBITOR AND ONE OR MORE ANTINEOPLASTIC AGENTS AS A COMBINATION THERAPY IN THE TREATMENT OF NEOPLASIA

摘要

For the treatment of mammals, such as those for treating a neoplasm, a combination of cyclooxygen z-2-g and antineoplastic agent, optionally surgical intervention and / or radiotherapy, is employed. This antineoplastic agent may be: anastrozole, calcium carbon t, capecitabine, carboplatin, cisplatin, Cell-Pathways CP-461, docetaxel, doxorubicin, etoposide, fluoxymestrin, gemcitabine, gozerelin, irinotecin, ketoconazole, letrozole, leukovorin, levamizole, estrole, mitoxantrone, paclitaxel, raloxifene, retinoic acid, tamoxifen, thiotepa, topotecin, toremifene, vinorelbine, vinblastine, vincristine, selenium (selenomethionone), sulindac sulfone, exemestine n and elfornitine (DFMO), not listed above. HE